TILRAY BRANDS INC (TLRY) Stock Fundamental Analysis

NASDAQ:TLRY • US88688T2096

7.87 USD
-0.12 (-1.5%)
At close: Feb 27, 2026
7.87 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

TLRY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. TLRY may be in some trouble as it scores bad on both profitability and health. TLRY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • TLRY had negative earnings in the past year.
  • TLRY had a negative operating cash flow in the past year.
  • In the past 5 years TLRY always reported negative net income.
  • TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY Yearly Net Income VS EBIT VS OCF VS FCFTLRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • TLRY has a Return On Assets of -100.42%. This is in the lower half of the industry: TLRY underperforms 77.08% of its industry peers.
  • The Return On Equity of TLRY (-133.40%) is worse than 67.71% of its industry peers.
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY Yearly ROA, ROE, ROICTLRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • TLRY's Gross Margin of 28.02% is in line compared to the rest of the industry. TLRY outperforms 57.29% of its industry peers.
  • TLRY's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TLRY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY Yearly Profit, Operating, Gross MarginsTLRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, TLRY has more shares outstanding
  • TLRY has more shares outstanding than it did 5 years ago.
  • TLRY has a worse debt/assets ratio than last year.
TLRY Yearly Shares OutstandingTLRY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY Yearly Total Debt VS Total AssetsTLRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of -1.61, we must say that TLRY is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of TLRY (-1.61) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.18 indicates that TLRY is not too dependend on debt financing.
  • TLRY has a Debt to Equity ratio (0.18) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.61
ROIC/WACCN/A
WACC8.45%
TLRY Yearly LT Debt VS Equity VS FCFTLRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • TLRY has a Current Ratio of 2.81. This indicates that TLRY is financially healthy and has no problem in meeting its short term obligations.
  • TLRY has a Current ratio (2.81) which is in line with its industry peers.
  • A Quick Ratio of 1.72 indicates that TLRY should not have too much problems paying its short term obligations.
  • TLRY has a Quick ratio of 1.72. This is comparable to the rest of the industry: TLRY outperforms 42.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 1.72
TLRY Yearly Current Assets VS Current LiabilitesTLRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • TLRY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -379.00%.
  • TLRY shows a small growth in Revenue. In the last year, the Revenue has grown by 0.98%.
  • TLRY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.52% yearly.
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%

3.2 Future

  • Based on estimates for the next years, TLRY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.42% on average per year.
  • The Revenue is expected to grow by 4.15% on average over the next years.
EPS Next Y96.56%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue Next Year3.75%
Revenue Next 2Y4.25%
Revenue Next 3Y4.03%
Revenue Next 5Y4.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TLRY Yearly Revenue VS EstimatesTLRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY Yearly EPS VS EstimatesTLRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • TLRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLRY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY Price Earnings VS Forward Price EarningsTLRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TLRY is valued cheaper than 80.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.49
TLRY Per share dataTLRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TLRY's earnings are expected to grow with 25.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.59%
EPS Next 3Y25.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TILRAY BRANDS INC

NASDAQ:TLRY (2/27/2026, 8:00:02 PM)

After market: 7.87 0 (0%)

7.87

-0.12 (-1.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-08
Earnings (Next)04-06
Inst Owners11.21%
Inst Owner Change-88.46%
Ins Owners0.35%
Ins Owner Change0.02%
Market Cap916.93M
Revenue(TTM)837.32M
Net Income(TTM)-2.11B
Analysts70.59
Price Target12.64 (60.61%)
Short Float %13.71%
Short Ratio1.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.49%
Min EPS beat(2)-100.98%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-1374.81%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-733.35%
EPS beat(12)2
Avg EPS beat(12)-748.47%
EPS beat(16)3
Avg EPS beat(16)-621.09%
Revenue beat(2)2
Avg Revenue beat(2)0.75%
Min Revenue beat(2)0.41%
Max Revenue beat(2)1.09%
Revenue beat(4)2
Avg Revenue beat(4)-4.75%
Min Revenue beat(4)-13.28%
Max Revenue beat(4)1.09%
Revenue beat(8)2
Avg Revenue beat(8)-5.24%
Revenue beat(12)3
Avg Revenue beat(12)-2.69%
Revenue beat(16)3
Avg Revenue beat(16)-3.19%
PT rev (1m)-8.23%
PT rev (3m)568.78%
EPS NQ rev (1m)6.67%
EPS NQ rev (3m)-833.33%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-1134.12%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 1.14
EV/EBITDA 22.49
EPS(TTM)-14.37
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS7.19
BVpS13.56
TBVpS6.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.02%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 7.07
Cap/Depr 40.31%
Cap/Sales 4.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 1.72
Altman-Z -1.61
F-Score3
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
EPS Next Y96.56%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%
Revenue Next Year3.75%
Revenue Next 2Y4.25%
Revenue Next 3Y4.03%
Revenue Next 5Y4.15%
EBIT growth 1Y41.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.23%
EBIT Next 3Y28.5%
EBIT Next 5Y17.22%
FCF growth 1Y-53.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.64%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.


What is the valuation status for TLRY stock?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY). This can be considered as Overvalued.


How profitable is TILRAY BRANDS INC (TLRY) stock?

TILRAY BRANDS INC (TLRY) has a profitability rating of 1 / 10.